Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 1986; Volume 30,Issue 6
  • You have access
    Widespread distribution of dihydropyridine-sensitive calcium channels in the central nervous system.
    S A Thayer, S N Murphy and R J Miller
    Molecular Pharmacology December 1986, 30 (6) 505-509;
  • You have access
    Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities.
    G K Hogaboom, M Cook, J F Newton, A Varrichio, R G Shorr, H M Sarau and S T Crooke
    Molecular Pharmacology December 1986, 30 (6) 510-519;
  • You have access
    Mechanism of zone-specific hepatic steatosis caused by valproate: inhibition of ketogenesis in periportal regions of the liver lobule.
    M J Olson, J A Handler and R G Thurman
    Molecular Pharmacology December 1986, 30 (6) 520-525;
  • You have access
    Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    L Noronha-Blob, V C Lowe, W J Kinnier and D C U'Prichard
    Molecular Pharmacology December 1986, 30 (6) 526-536;
  • You have access
    Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
    S Meloche, H Ong, M Cantin and A De Léan
    Molecular Pharmacology December 1986, 30 (6) 537-543;
  • You have access
    High yield photoaffinity labeling of angiotensin II receptors.
    G Guillemette, G Guillon, J Marie, M N Balestre, E Escher and S Jard
    Molecular Pharmacology December 1986, 30 (6) 544-551;
  • You have access
    Proteolytic processing of atriopeptin prohormone.
    M L Michener, J K Gierse, R Seetharam, K F Fok, P O Olins, M S Mai and P Needleman
    Molecular Pharmacology December 1986, 30 (6) 552-557;
  • You have access
    Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.
    J F Puig and T R Tephly
    Molecular Pharmacology December 1986, 30 (6) 558-565;
  • You have access
    Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
    J H Brown and D Goldstein
    Molecular Pharmacology December 1986, 30 (6) 566-570;
  • You have access
    Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers.
    S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter
    Molecular Pharmacology December 1986, 30 (6) 571-584;
  • You have access
    Relationships of the molecular structure of aldosterone derivatives with their binding affinity for mineralocorticoid receptor.
    M Yamakawa, K Ezumi, M Shiro, H Nakai, S Kamata, T Matsui and N Haga
    Molecular Pharmacology December 1986, 30 (6) 585-589;
  • You have access
    The glycine receptor: pharmacological studies and mathematical modeling of the allosteric interaction between the glycine- and strychnine-binding sites.
    J C Marvizón, J Vázquez, M García Calvo, F Mayor, A Ruíz Gómez, F Valdivieso and J Benavides
    Molecular Pharmacology December 1986, 30 (6) 590-597;
  • You have access
    Activation and inhibition of 3H-strychnine binding to the glycine receptor by Eccles' anions: modulatory effects of cations.
    J C Marvizón, M García Calvo, J Vázquez, F Mayor, A Ruíz Gómez, F Valdiviesco and J Benavides
    Molecular Pharmacology December 1986, 30 (6) 598-602;
  • You have access
    Ability of guanine nucleotide derivatives to bind and activate bovine transducin.
    D J Kelleher, L W Dudycz, G E Wright and G L Johnson
    Molecular Pharmacology December 1986, 30 (6) 603-608;
  • You have access
    LY195115: a potent, selective inhibitor of cyclic nucleotide phosphodiesterase located in the sarcoplasmic reticulum.
    R F Kauffman, V G Crowe, B G Utterback and D W Robertson
    Molecular Pharmacology December 1986, 30 (6) 609-616;
  • You have access
    Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
    R S Sheldon, N J Cannon and H J Duff
    Molecular Pharmacology December 1986, 30 (6) 617-623;
  • You have access
    Hexose-independent activation of glycogen synthase and pyruvate dehydrogenase by insulin is dissociated in the mouse BC3H-1 cell line.
    L M Luttrell and A D Rogol
    Molecular Pharmacology December 1986, 30 (6) 624-630;
  • You have access
    The actions of dimethyl sulfoxide on neuromuscular transmission.
    J G McLarnon, D A Saint and D M Quastel
    Molecular Pharmacology December 1986, 30 (6) 631-638;
  • You have access
    Vitamin D3 derivatives inhibit the differentiation of Friend erythroleukemia cells.
    J K Wang, M D Johnson, J I Morgan and S Spector
    Molecular Pharmacology December 1986, 30 (6) 639-642;
  • You have access
    Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion.
    P A Andrews, M P Murphy and S B Howell
    Molecular Pharmacology December 1986, 30 (6) 643-650;
  • You have access
    Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).
    R G Richards, O E Brown, M L Gillison and W D Sedwick
    Molecular Pharmacology December 1986, 30 (6) 651-658;
  • You have access
    Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    S M Jarvis
    Molecular Pharmacology December 1986, 30 (6) 659-665;
  • You have access
    Cooxidation of styrene by horseradish peroxidase and glutathione.
    P R Ortiz de Montellano and L A Grab
    Molecular Pharmacology December 1986, 30 (6) 666-669;
  • You have access
    Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    G J Kontoghiorghes
    Molecular Pharmacology December 1986, 30 (6) 670-673;
  • You have access
    Metabolic activation of phenol by human myeloperoxidase and horseradish peroxidase.
    D A Eastmond, M T Smith, L O Ruzo and D Ross
    Molecular Pharmacology December 1986, 30 (6) 674-679;
  • You have access
    Substrate specificity of the rabbit lung flavin-containing monooxygenase for amines: oxidation products of primary alkylamines.
    L L Poulsen, K Taylor, D E Williams, B S Masters and D M Ziegler
    Molecular Pharmacology December 1986, 30 (6) 680-685;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 30, Issue 6
1 Dec 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics